A study published in Nature confirms that newly proposed obesity diagnostic criteria could identify obesity more accurately than body mass index alone, potentially reducing both misdiagnosis and missed diagnoses.

The framework, developed by a Lancet Commission of 56 experts chaired by Dr. Francesco Rubino of King's College London, uses body measurements beyond BMI alongside medical history review. The proposed measurements include waist circumference, waist-to-hip ratio, and waist-to-height ratio, which are less influenced by muscle mass or bone structure than BMI. The criteria also assess 18 conditions related to obesity, such as cardiovascular disease, joint pain, and sleep apnea.

The new system distinguishes between "preclinical obesity," where a person risks developing obesity-related dysfunction, and "clinical obesity," where at least one form of bodily dysfunction caused by excess fat is already present. Dr. Aayush Visaria, an internal medicine instructor at Rutgers Robert Wood Johnson Medical School, noted that more consensus is needed on what defines clinical obesity, as diagnostic metrics contain ambiguities.

Using electronic health records from China, the United Kingdom, the United States, and Spain, researchers found that clinical obesity was linked to a 69 percent greater risk of all-cause mortality compared to no obesity. They found no clear association between BMI and mortality risk.

BMI fails to account for differences in muscle mass and bone density between individuals. Different racial and ethnic groups experience health consequences at different BMI levels. The new framework incorporates ethnicity-specific waist circumference cutoffs to account for variations in fat distribution patterns.

Implementation faces challenges. Clinicians would need training to perform body measurements accurately. The distinction between preclinical and clinical obesity could create complications, with some patients losing medication eligibility under Food and Drug Administration guidelines if reclassified as having preclinical obesity.

The new criteria would increase obesity prevalence by approximately 3.3 to 7.4 percent overall, with variation depending on the population analyzed. Some people with BMIs under 30 would be newly classified as clinically obese, while others with high BMIs would no longer count as clinically obese.

Dr. Jennifer Hwang, an instructor of medicine at the University of Chicago, said more research is needed to prove the criteria would improve patient care and prove practical in clinical settings. The Lancet Commission plans to continue validating the framework and determining which forms of organ dysfunction pose the greatest concern.